Human Body: The Secret Chamber of SARS-CoV-2
Abstract
Background: A larger number of people have been affected with COVID-19 and the number of survivors is increasing day by day. Recently many reports on health issues have been arising from various corners of the world. This raises the question of whether SARS-CoV-2 has a long term impact on our health conditions or will it persist in the human body. This work peeps into such concerns of COVID-19 survivors.
Objective: This study focuses on the persistence and sequelae of SARS-CoV-2 in COVID-19 survivors.
Methods: A survey was conducted among COVID-19 survivors of Kerala, India to analyse the long term health impacts of COVID-19. 294 COVID-19 survivors participated in the survey and Google form was the key tool used in the study. The results obtained were compared with published research papers and articles to check for the probability of persistence of SARS-CoV-2.
Results: SARS-CoV-2 poses long term health issues for survivors. Majority of the participants (64.2%) reported that they have neurological, reproductive and musculoskeletal symptoms. The present study on the mode of entry of virus and immune-privileged sites in the human body, when compared to reported works earlier suggests that the chance of persistence of SARS-CoV-2 in the human body is higher as this virus has a noticeable potency to infect immune-privileged sites.
Conclusion: Most of the survivors face numerous difficulties even after laboratory tests shows them negative for COVID-19 and hence the question ‘whether the human body will act as a reservoir for SARS-CoV-2’ cannot be neglected. Further studies are to be conducted in this regard and emphasis should be on establishing more post-COVID clinics.
How to cite this article:
Sandra SN, Rajendran A, Regi MK, Sheeba P, John F. Human Body: The Secret Chamber of SARS-CoV-2. Special Issue - COVID-19 & Other Communicable Disease. 2022;98-102.
DOI: https://doi.org/10.24321/0019.5138.202215
References
Payne S. Family Coronaviridae. Viruses. 2017:149-58.
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265-9. [PubMed] [Google Scholar]
World Health Organisation [Internet]. WHO Coronavirus (COVID-19) Dashboard; [cited2021 May 15]. Available from:https://covid19.who.int/
Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S, Rosaria Barillari M, Cammaroto G, Fakhry N, Martiny D, Ayad T, Jouffe L, Hopkins C, Saussez S; COVID-19 Task Force of YO-IFOS.Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. J Intern Med. 2020 Sep;288(3):335-44.[PubMed] [Google Scholar]
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497-506.[PubMed] [Google Scholar]
Zhou R, Li F, Chen F, Liu H, Zheng J, Lei C, Wu X. Viral dynamics in asymptomatic patients with COVID-19. Int J Infect Dis. 2020 Jul;96:288-90. [PubMed] [Google Scholar]
Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. ClinMicrobiol Infect. 2021 Jan;27(1):89-95. [PubMed] [Google Scholar]
Datta PK, Liu F, Fischer T, Rappaport J, Qin X. SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics. 2020 Jun;10(16):7448-64. [PubMed] [Google Scholar]
Ortega JT, Serrano ML, Pujol FH, Rangel HR. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI J. 2020 Mar;19:410-7. [PubMed] [Google Scholar]
Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021 Mar;18(5):2621. [PubMed] [Google Scholar]
Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 chronic symptoms: a post infectious entity? ClinMicrobiol Infect. 2020 Nov;26(11):1448-9.[PubMed] [Google Scholar]
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020 Jun;92(6):552-5. [PubMed] [Google Scholar]
Forrester JV, McMenamin PG, Dando SJ. CNS infection and immune privilege. Nat Rev Neurosci. 2018 Nov;19(11):655-71. [PubMed] [Google Scholar]
Dejucq N, JégouB.Viruses in the mammalian male genital tract and their effects on the reproductive system. MicrobiolMolBiol Rev. 2001 Jun;65(2):208-31.[PubMed] [Google Scholar]
Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H, Shen H, Qiu L, Li Z, Geng J, Cai J, Han H, Li X, Kang W, Weng D, Liang P, Jiang S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications forpathogenesis and virus transmission pathways. J Pathol. 2004 Jun;203(2):622-30. [PubMed] [Google Scholar]
Xu J, Qi L, Chi X, Yang J, Wei X, Gong E, Peh S, Gu J. Orchitis:a complication of severe acute respiratory syndrome (SARS). BiolReprod. 2006 Feb;74(2):410-6. [PubMed] [Google Scholar]
Shastri A, WheatJ, Agrawal S, ChaterjeeN,Pradhan K, Goldfinger M, Kornblum N, Steidl U, Verma A, ShastriJ.Delayed clearance of SARS-CoV2 in male compared to female patients: high ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs. medRxiv:20060566v1 [Preprint].2020. Availablefrom: https://www.medrxiv.org/content/10.1101/2020.04.16.20060566v1. [Google Scholar] Acess date: 13 June 2021
Cardona Maya WD, Du Plessis SS, Velilla PA. SARS-CoV-2 and the testis: similarity with other viruses and routes of infection. Reprod Biomed Online. 2020 Jun;40(6):763-4. [PubMed] [Google Scholar]
Fijak M, Bhushan S, Meinhardt A. Immunoprivileged sites: the testis. Methods Mol Biol. 2011 Jun;677:459-70. [PubMed] [Google Scholar]
Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, Asensio S, Sanchez R, Ruiz-Torregrosa P, Galan I, Scholz A, Amo A, González-delaAleja P, Boix V, Gil J; COVID19-ALC Research Group. Post-acute COVID-19 syndrome. Incidence and risk factors: aMediterranean cohort study. J Infect. 2021 Mar;82(3):378-83.[PubMed] [Google Scholar]
Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O’Connor RJ, Sivan M.Postdischarge symptoms andrehabilitation needs in survivors of COVID-19 infection: across-sectional evaluation. J Med Virol. 2021 Feb;93(2):1013-22. [PubMed] [Google Scholar]
Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul;69:993-8.[PubMed] [Google Scholar]
Carfì A, Bernabei R, Landi F; GemelliagainstCOVID-19 Post-Acute Care Study Group.Persistent symptoms in patients after acute COVID-19. JAMA. 2020 Aug;324(6):603-5.[PubMed] [Google Scholar]
Copyright (c) 2022 Author's
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
